The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes
- PMID: 17259492
- DOI: 10.2337/dc06-1612
The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes
Abstract
Objective: The aim of the study was to determine whether the loss of fasting and postprandial glycemic control occurs in parallel or sequentially in the evolution of type 2 diabetes.
Research design and methods: In 130 type 2 diabetic patients, 24-h glucose profiles were obtained using a continuous glucose monitoring system. The individuals with type 2 diabetes were divided into five groups according to A1C levels: 1 (<6.5%, n = 30), 2 (6.5-6.9%, n = 17), 3 (7-7.9%, n = 32), 4 (8-8.9%, n = 25), and 5 (> or =9%, n = 26). The glucose profiles between the groups were compared. The overall glucose concentrations for the diurnal, nocturnal, and morning periods, which represent the postprandial, fasting, and the dawn phenomenon states, respectively, were also compared.
Results: Glucose concentrations increased steadily from group 1 to 5 in a stepwise manner. The initial differences in mean glucose concentrations reaching statistical significance occurred 1) between groups 1 and 2 (6.4 vs. 7.7 mmol/l, P = 0.0004) for daytime postprandial periods, followed by differences; 2) between groups 2 and 3 (7.5 vs. 9.3 mmol/l, P = 0.0003) for the morning periods (dawn phenomenon); and finally 3) between groups 3 and 4 (6.3 vs. 8.4 mmol/l, P < 0.0001) for nocturnal fasting periods.
Conclusions: The deterioration of glucose homeostasis in individuals with type 2 diabetes progressed from postprandial to fasting hyperglycemia following a three-step process. The first step related to the three diurnal postmeal periods considered as a whole, the second step occurred during the morning period, and the third and final step corresponded to sustained hyperglycemia over the nocturnal fasting periods. Such a description of the key stages in the evolution of type 2 diabetes may be of interest for implementing antidiabetes treatment.
Similar articles
-
Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).Diabetes Care. 2003 Mar;26(3):881-5. doi: 10.2337/diacare.26.3.881. Diabetes Care. 2003. PMID: 12610053
-
Postprandial plasma glucose: a good index of glycemic control in type 2 diabetic patients having near-normal fasting glucose levels.Diabetes Res Clin Pract. 1999 Oct;46(1):23-7. doi: 10.1016/s0168-8227(99)00061-3. Diabetes Res Clin Pract. 1999. PMID: 10580612
-
Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.Clin Ther. 2007 Nov;29(11):2349-64. doi: 10.1016/j.clinthera.2007.11.016. Clin Ther. 2007. PMID: 18158076 Clinical Trial.
-
Contributions of fasting and postprandial glucose to hemoglobin A1c.Endocr Pract. 2006 Jan-Feb;12 Suppl 1:42-6. doi: 10.4158/EP.12.S1.42. Endocr Pract. 2006. PMID: 16627379 Review.
-
"Mild dysglycemia" in type 2 diabetes: to be neglected or not?J Diabetes Complications. 2015 Apr;29(3):451-8. doi: 10.1016/j.jdiacomp.2014.12.004. Epub 2014 Dec 12. J Diabetes Complications. 2015. PMID: 25572605 Review.
Cited by
-
Stepwise intensification of insulin therapy in type 2 diabetes management--exploring the concept of the basal-plus approach in clinical practice.Diabet Med. 2013 Mar;30(3):276-88. doi: 10.1111/dme.12019. Diabet Med. 2013. PMID: 22998363 Free PMC article. Review.
-
Utility of different glycemic control metrics for optimizing management of diabetes.World J Diabetes. 2015 Feb 15;6(1):17-29. doi: 10.4239/wjd.v6.i1.17. World J Diabetes. 2015. PMID: 25685275 Free PMC article. Review.
-
Progress and application of adipose-derived stem cells in the treatment of diabetes and its complications.Stem Cell Res Ther. 2024 Jan 2;15(1):3. doi: 10.1186/s13287-023-03620-0. Stem Cell Res Ther. 2024. PMID: 38167106 Free PMC article. Review.
-
Can postprandial blood glucose excursion be predicted in type 2 diabetes?Diabetes Care. 2010 Sep;33(9):1913-8. doi: 10.2337/dc10-0115. Epub 2010 Jun 14. Diabetes Care. 2010. PMID: 20551017 Free PMC article.
-
Exploring the insulin secretory properties of the PGD2-GPR44/DP2 axis in vitro and in a randomized phase-1 trial of type 2 diabetes patients.PLoS One. 2018 Dec 17;13(12):e0208998. doi: 10.1371/journal.pone.0208998. eCollection 2018. PLoS One. 2018. PMID: 30557325 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical